Having cleared the hurdle as a treatment for diabetes, the FDA then approved semaglutide, marketed as Wegovy, for obesity in 2021, and then in Europe the following year
Additional studies earlier this year have shown no significant increased risk or only a modest increase. But just this summer, the European Medicines Agency conducted a safety review and recommended that product information for semaglutide medicines (namely Ozempic, Rybelsus and Wegovy) be updated to include NAION as a side effect with a frequency of very rare. The EMAs Safety Committee also issued this advice: If patients experience a sudden loss of vision or rapidly worsening eyesight during treatment with semaglutide, they should contact their doctor without delay
Zatorski H, Saaga M, Zieliska M et al (2015) Experimental colitis in mice is attenuated by topical administration of chlorogenic acid
In fact, excess oil, frequent cleansing, and over-exfoliation can weaken your skin's protective barrier over time
Beyond the Medication: Semaglutide vs
Khng cn dng liu qu cao ngay t u 3